Cover Image
Market Research Report
Product code 
1073616

Optical Devices for Monitoring Patient Glucose Levels

Published: | Greystone Research Associates | 100 Pages | Delivery time: 1-2 business days

Price

Back to Top
Optical Devices for Monitoring Patient Glucose Levels
Published: May 9, 2022
Greystone Research Associates
Content info: 100 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors. For patient with chronic conditions monitoring is a way of life, Now the convergence of small-scale electronics and sophisticated biocompatible product designs is providing a better way to manage chronic conditions for patients worldwide. Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing. By integrating the sensing element, electronics, and0 a power source in a single package, noninvasive monitors are creating new options for caregivers and their patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors.

What You Will Learn:

  • What are the noninvasive sensing and monitoring technologies that are being pursued, who are the players behind them, and what is their development status?
  • What are the key noninvasive optical monitoring device design issues and evolving market factors?
  • What is the global market potential for optical monitors today? What will it be in 2024?
  • What will be the likely impact of the availability of commercial noninvasive sensing technology and devices on disease management markets?
  • Who are the market participants in the noninvasive monitoring sector? What are their technologies, product development activities and business strategies?
  • What will be the impact of economic, technology, and regulatory factors on the commercial potential of optical device patient monitors?
Product Code: PGM377K

Table of Contents

  • Executive Summary
  • Glucose Sensing Market Overview
  • Monitoring Glucose Levels
  • Key Factors in Patient Compliance
  • Market Drivers
  • Industry Alignment and Competitive Landscape
  • Noninvasive Glucose Measurement Design Factors
  • Measuring Glucose in Interstitial Fluid
  • Patient/User Interface
  • Reliability
  • Data Collection & Reporting
  • Commercial Track NGM Technologies
  • Spectroscopy
  • Raman
  • Infrared
  • Reverse Iontophoresis
  • Continuous Glucose Monitoring
  • Near-term Noninvasive Glucose Measurement Device Analysis
  • Optical Data Collection
  • Direct Analyte Measurement
  • Multimode Sensing
  • Forecasts
  • Important Private Research Programs
  • Asia
  • Soompo Japan Research Institute
  • Toyama Medical And Pharmaceutical University (Japan)
  • North America
  • Juvenile Diabetes Research Foundation (USA)
  • Juvenile Diabetes Research Foundation (USA)
  • Europe
  • Medical University of Graz (Austria)
  • Medical Research Foundation (The Netherlands)
  • Commercialization Factors
  • Calibration Frequency
  • Accuracy & Precision
  • Sensitivity
  • Sensor Technology & Signal Processing Advances
  • Market Factors
  • Regulations
  • FDA
  • EMEA
  • Asia (Japan)
  • Clinical Trials
  • Company Profiles